title: Effects of HOE 140 on some renal functions in type I diabetic mice.
abstract: To investigate in mice the mechanisms underlying renal functions in a type I diabetes model, we have suppressed B2 kinin receptors local activities by their specific antagonist D-Arg [Hyp3-Thi5-D-Tic7-Oic8]BK (HOE 140). Mice made diabetic with low consecutive doses of streptozotocin (STZ) (45 mg/k BW during 5 days) were injected with HOE 140 (15 micrograms/twice a day) for 15 days. This drug did not modify glycemia of STZ treated animals but a significantly reduction of urinary proteins, nitrites and kallikrein was observed. These results indicate that kinin B2-receptors activation is implicated in the alterations of renal function in this model of type I diabetes in mice.
authors.affiliation: Peosivad-Conicet. Catedra de Fisiologia. Facultad de Farmacia y Bioquimica-Universidad Buenos Aires, Argentina.
authors.forename: A
authors.initials: A
authors.lastname: Zuccollo
authors.forename: M
authors.initials: M
authors.lastname: Navarro
authors.forename: G M
authors.initials: GM
authors.lastname: Prendes
authors.forename: A
authors.initials: A
authors.lastname: Dominguez
authors.forename: O L
authors.initials: OL
authors.lastname: Catanzaro
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D001920:Bradykinin / Q000031:analogs & derivatives* / Q000494:pharmacology; D065168:Bradykinin Receptor Antagonists; D003921:Diabetes Mellitus, Experimental / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D003928:Diabetic Nephropathies / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D007677:Kidney Function Tests; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL
chemical_list: D001786:Blood Glucose; D065168:Bradykinin Receptor Antagonists; C065679:icatibant; D001920:Bradykinin